0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Peptides in Oncology I - LH-RH Agonists and Antagonists (Paperback, Softcover reprint of the original 1st ed. 1992) Loot Price: R1,464
Discovery Miles 14 640
Peptides in Oncology I - LH-RH Agonists and Antagonists (Paperback, Softcover reprint of the original 1st ed. 1992): K. Hoeffken

Peptides in Oncology I - LH-RH Agonists and Antagonists (Paperback, Softcover reprint of the original 1st ed. 1992)

K. Hoeffken

Series: Recent Results in Cancer Research, 124

 (sign in to rate)
Loot Price R1,464 Discovery Miles 14 640 | Repayment Terms: R137 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Hormonal treatment of malignant diseases has been used for quite some years now, and progress in this field is still being made at a steady pace. The detection of new endocrine feed back loops and the availability of new classes of hormonal agents made hormonal intervention with predictable outcome possible. Besides the intellectual challenge of modulating the hormone system, an important aspect of recent research on hormones and cancer is the reduction of treatment-related morbidity achieved with the new hormonal strategies. Thus, controlled intervention in the hypothalamic-gonadotropic axis is increasingly apt to replace surgical removal of the relevant glands, i. e., the pituitary gland or the gonads. In the same way as, for example, aromatase inhibitors are being used as a substitute for adrenalectomy. The concept that secretion of hypothalamic gonadotropin releasing hormone (GnRH), pituitary gonadotropins, and sex steroids are regulated via negative and positive feedback loops is based on the pioneering work of Hohlweg and Harris some 40 years ago. In 1971, a breakthrough was achieved with the isolation, structural analysis, and synthesis of the luteinizing hormone releasing hormone (LH-RH), or GnRH as it is now more appropriately termed, since it provokes the secretion of both gonadotropins, LH and FSH, and since then the progress made in this area of research has been remarkable. Both ago nists and antagonists of LH-RH have been synthesized and extensively studied in preclinical and clinical settings."

General

Imprint: Springer-Verlag
Country of origin: Italy
Series: Recent Results in Cancer Research, 124
Release date: December 2011
First published: 1992
Editors: K. Hoeffken
Dimensions: 235 x 155 x 8mm (L x W x T)
Format: Paperback
Pages: 141
Edition: Softcover reprint of the original 1st ed. 1992
ISBN-13: 978-88-470-2188-4
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 88-470-2188-X
Barcode: 9788847021884

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners